Related Experiment Video
Updated: Jul 3, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Predicting impacts of mass-screening policy changes on breast cancer mortality
Johanna Seppänen1, Sirpa Heinävaara, Timo Hakulinen
1Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland. johanna.seppanen@cancer.fi
Abstract:
The aim of this study is to present a methodology for taking into account the mass-screening invitation data in breast cancer mortality predictions, particularly in assessing impacts of screening policy changes on the short-term predictions. The methodology is applied to a database that includes observed year- and age-specific screening invitation schemes in Finnish municipalities from the time period 1987-2001. The target year for predictions is 2012. To predict mortality, breast cancer incidence and patients' survival from breast cancer are modelled with the screening data included. The knowledge of breast cancer survival together with the other cause survival is then used to calculate the number of breast cancer deaths caused by observed (1987-2001) and predicted (2002-2012) incident cases in Finland. Survival from breast cancer was estimated with a parametric mixture model where the patient population is assumed to be a combination of cured and uncured patients. This approach provides a way of modelling the hazard of fatal cases and the proportion of cured cases simultaneously. In other cause survival, the patients' hazard was allowed to differ from that of the general population. Breast cancer mortality predictions are presented according to three alternative future scenarios of screening policy. The results show no major differences between predictions yielded by alternative scenarios: Any policy change would have at the most a 3.0 per cent impact on breast cancer mortality in the near future.
Related Concept Videos
Cancer Survival Analysis
Kaplan-Meier Approach
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Comparing the Survival Analysis of Two or More Groups